澳大利亚Telectronics Pty有限公司最近推出Meta MV1202型心脏起搏器。该起搏器经设计使病人心率与新陈代谢需要相关,成为一种极像正常心脏搏动的生理心率型起搏器。微小体积的变化,即吸入的空气量有些微变化,作为新陈代谢需要指示。心脏起搏器通过测量心阻抗,监视微小体积的变化,据此调节病人心率。这样,允许心脏起搏器在对心输出量有作 Australia’s Telectronics Pty Ltd recently introduced the Meta MV1202 pacemaker. The pacemaker is designed to make the patient’s heart rate and metabolic needs related to become a kind of physiological heart rate pacemaker like a normal heart beat. Small changes in the volume, that is, the amount of inhaled air slightly changed, as an indicator of metabolism. Cardiac pacemakers monitor heart rate, monitor small volume changes, and adjust patient heart rate accordingly. This allows the pacemaker to work on cardiac output